IL6 and myeloid sarcoma: Indeed, although IL-6 levels in the CSF of MS patients have reported to be unaltered, likely indicating that IL-6 is not a specific signature of the disease [41], it can be hypothesized that this cytokine has a local role in the modulation of the inflammatory reaction, since its expression was detected in glial cells of MS lesions [42].